MedTrace Logo

ARMA (Antireflux Mucosa Ablation) in Patients With Chronic Refractory Reflux Disease

NCT05425771 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2022-07-14

No results posted yet for this study

Summary

Pilot study of the possible clinical response to anti reflux mucosal ablation in patients with chronic refractory reflux disease

Conditions

  • Gastro-esophageal Reflux
  • Reflux, Gastroesophageal

Interventions

PROCEDURE

Anti Reflux Mucosa Ablation

Mucosa ablation with Argon plasma coagulation performed in inversion at the gastroesophageal junction in a crescent or horseshoe shape over a width of 1.5 - 2 cm in patients with refractory reflux symptoms

Sponsors & Collaborators

  • Klinikum Garmisch-Patenkirchen

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-14
Primary Completion
2022-12-31
Completion
2023-05-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05425771 on ClinicalTrials.gov